Results 41 to 50 of about 641,939 (299)

Second report on containers [PDF]

, 1968
In our first report on containers published in January,1967, we tried to summarise progress in this new mode of transportation and to define some of the problems which ...
Kay, E., Pemberton, A. W.
core  

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges, Kelly A. Duffy, Sara McDonough, Evelyn Kurpiewski, R. Jennifer Randall, Allison Barz Leahy, Haley M. Newman, Joyce P. Lee, Stephen P. Hunger, Anne F. Reilly, David T. Teachey, Susan R. Rheingold, Daniel J. Zheng   +12 more
wiley   +1 more source

Apparatus for sequentially transporting containers [PDF]

, 1982
Apparatus for transferring and manipulating a plurality of containers in a sequence is disclosed including a mechanical manipulator arm having a gripping device which automatically picks up a container at a fixed pickup position P and transfers it to a ...
Hudgins, J. L.
core   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

First report on containers [PDF]

, 1966
Everybody agrees that containers are a "good thing";the actual advantages of transporting cargo, and in particular, dry cargo, in containers over other forms of transport have, to our knowledge, nowhere been stated in quantitative terms.
Kay, E., Pemberton, A. W.
core  

Contained Hypermedia

, 1996
JUCS - Journal of Universal Computer Science Volume Nr.
Duval,Erik, Olivié,Henk, Scherbakov,Nick   +2 more
openaire   +3 more sources

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine, Ofélie Trudeau‐Ferrin, Caroline Laverdière, Patrick Hamel, Rosanne Superstein, Bénédicte Koukoui, Carole Provost, Paul C. Nathan, Vijay Ramaswamy, Furqan Shaikh, Brenda Gallie, Ashwin Mallipatna, Stephanie Kletke, Helen Dimaras, Hallie Coltin   +14 more
wiley   +1 more source

Resistance Analysis of a Plastic Container Obtained with Additive Manufacturing Using Finite Elements

Journal of Manufacturing and Materials Processing
Traditional manufacturing processes yield plastic containers in large batches, even for minimal production runs, resulting in elevated production costs.
Luis M. López-López, Geovanny Maldonado, Cesar Paltán-Zhingre, Jimmy Brito, Julio Loja-Quezada, Marco Amaya-Pinos   +5 more
doaj   +1 more source

Toward Smart Moving Target Defense for Linux Container Resiliency

, 2016
This paper presents ESCAPE, an informed moving target defense mechanism for cloud containers. ESCAPE models the interaction between attackers and their target containers as a "predator searching for a prey" search game. Live migration of Linux-containers
Abed, Amr S., Azab, Mohamed, Eltoweissy, Mohamed, Mokhtar, Bassem   +3 more
core   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source